Philippe Bernard

14.0k total citations
269 papers, 7.4k citations indexed

About

Philippe Bernard is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Philippe Bernard has authored 269 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pathology and Forensic Medicine, 67 papers in Rheumatology and 52 papers in Genetics. Recurrent topics in Philippe Bernard's work include Autoimmune Bullous Skin Diseases (75 papers), Urticaria and Related Conditions (47 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (45 papers). Philippe Bernard is often cited by papers focused on Autoimmune Bullous Skin Diseases (75 papers), Urticaria and Related Conditions (47 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (45 papers). Philippe Bernard collaborates with scholars based in France, Switzerland and United States. Philippe Bernard's co-authors include Frank Antonicelli, C. Bédane, Thomas Scior, Quoc‐Tuan Do, Jean-Marie Bonnetblanc, Marcel Hibert, A. Durlach, P. Joly, Patrice Tran Ba Huy and Jochen Schacht and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Philippe Bernard

254 papers receiving 7.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Philippe Bernard 3.3k 2.9k 2.6k 1.3k 918 269 7.4k
Robert Gniadecki 2.1k 0.6× 730 0.3× 395 0.2× 1.9k 1.5× 1.7k 1.8× 269 8.9k
Kapil N. Bhalla 1.3k 0.4× 1.9k 0.6× 3.7k 1.4× 17.3k 13.4× 1.7k 1.9× 378 26.0k
M. Eileen Dolan 629 0.2× 288 0.1× 1.3k 0.5× 6.5k 5.0× 347 0.4× 220 10.5k
Andreas Scorilas 857 0.3× 409 0.1× 3.8k 1.4× 7.3k 5.6× 357 0.4× 429 13.8k
Harald Gollnick 542 0.2× 793 0.3× 241 0.1× 2.1k 1.6× 1.2k 1.3× 291 9.8k
Donna M. Peehl 1.6k 0.5× 374 0.1× 259 0.1× 5.6k 4.3× 430 0.5× 211 11.8k
Guy Laurent 1.2k 0.3× 175 0.1× 695 0.3× 3.9k 3.0× 303 0.3× 197 7.3k
Kenneth H. Cowan 1.0k 0.3× 672 0.2× 380 0.1× 7.6k 5.8× 524 0.6× 195 13.4k
Spiridione Garbisa 888 0.3× 374 0.1× 287 0.1× 3.2k 2.5× 404 0.4× 139 9.3k
Timothy J. McDonnell 2.1k 0.6× 184 0.1× 1.3k 0.5× 8.3k 6.4× 791 0.9× 190 13.5k

Countries citing papers authored by Philippe Bernard

Since Specialization
Citations

This map shows the geographic impact of Philippe Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bernard more than expected).

Fields of papers citing papers by Philippe Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bernard. The network helps show where Philippe Bernard may publish in the future.

Co-authorship network of co-authors of Philippe Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Bernard. A scholar is included among the top collaborators of Philippe Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Bernard. Philippe Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aci‐Sèche, Samia, et al.. (2024). Virtual screening of natural products to enhance melanogenosis. Molecular Informatics. 43(9). e202300335–e202300335. 1 indexed citations
2.
Frossard, Nelly, Jean‐Luc Galzi, Carey Suehs, et al.. (2024). Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis. International Journal of Cosmetic Science. 46(3). 468–477. 2 indexed citations
3.
Bernard, Philippe, et al.. (2024). Management of Melanoma in Elderly Patients over 80 Years. Acta Dermato Venereologica. 104. adv41029–adv41029.
4.
Aubin, Henri‐Jean, Ivan Berlin, Jacques Bruhwyler, et al.. (2024). Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double‐blind, placebo‐controlled trial. Addiction. 119(7). 1211–1223. 1 indexed citations
5.
Gérard, E., Célèste Lebbé, Émilie Lanoy, et al.. (2023). 1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA. Annals of Oncology. 34. S683–S683. 3 indexed citations
6.
Rakers, Christin, et al.. (2021). A Cornflower Extract Containing N‐Feruloylserotonin Reduces Inflammation in Human Skin by Neutralizing CCL17 and CCL22 and Inhibiting COX‐2 and 5‐LOX. Mediators of Inflammation. 2021(1). 6652791–6652791. 13 indexed citations
8.
Giusti, Delphine, Sébastien Le Jan, Grégory Gatouillat, et al.. (2017). Biomarkers related to bullous pemphigoid activity and outcome. Experimental Dermatology. 26(12). 1240–1247. 17 indexed citations
9.
Bettayeb, Karima, Yoan Ferandin, Florence Popowycz, et al.. (2008). N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine. Molecular Cancer Therapeutics. 7(9). 2713–2724. 47 indexed citations
10.
Gisserot, O., et al.. (2008). ImageUne fausse polyarthrite rhumatoïdeA wrong rheumatoid arthritis. La Revue de Médecine Interne. 29(2).
11.
Bernard, Philippe, et al.. (2008). Basal Cell Carcinomas and Actinic Keratoses Seen in Dermatological Practice in France: A Cross-Sectional Survey. Dermatology. 216(3). 194–199. 34 indexed citations
12.
Bernard, Philippe, A. Dupuy, P. Brun, et al.. (2007). Évaluation médico-économique de la prise en charge des carcinomes basocellulaires superficiels et des kératoses actiniques multiples par les dermatologues français. Annales de Dermatologie et de Vénéréologie. 134(6-7). 527–533. 7 indexed citations
13.
Baranek, Thomas, Romain Debret, Frank Antonicelli, et al.. (2007). Elastin Receptor (Spliced Galactosidase) Occupancy by Elastin Peptides Counteracts Proinflammatory Cytokine Expression in Lipopolysaccharide-Stimulated Human Monocytes through NF-κB Down-Regulation. The Journal of Immunology. 179(9). 6184–6192. 34 indexed citations
14.
Drouet, M, et al.. (2000). HLA and susceptibility to two distinct types of drug-induced cutaneous reactions. European Journal of Dermatology. 7(5). 329–332. 2 indexed citations
15.
Bernard, Philippe, et al.. (1991). [Nevus of Ota and benign cutaneous blue nevus associated with malignant cerebromeningeal melanoma].. PubMed. 118(10). 707–9. 2 indexed citations
16.
Bonnetblanc, Jean-Marie, M. Drouet, P M Laplaud, Christophe Bédane, & Philippe Bernard. (1990). Urticaria with Macroglobulinaemia. Dermatology. 181(1). 41–43. 16 indexed citations
17.
Bernard, Philippe, et al.. (1987). Vascularite cutanée localisée induite par la nétilmicine sous-cutanée.. La Presse Médicale. 16(18). 915–916. 2 indexed citations
18.
Huy, Patrice Tran Ba, Philippe Bernard, & Jochen Schacht. (1986). Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs.. Journal of Clinical Investigation. 77(5). 1492–1500. 207 indexed citations
19.
Balansard, G., et al.. (1980). Douvicidal and antifungal activities of alpha -hederin extracted from Hedera helix leaves.. Planta Medica. 39(3). 3 indexed citations
20.
Bernard, Philippe. (1975). La fin d'un monde : 1914-1929. Seuil eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026